What are the recent financial highlights of THEMIS MEDICARE LTD.?

THEMIS MEDICARE LTD. recently reported a total revenue of ₹431.63 Cr and a net profit margin of 10.69%. These metrics reflect the company’s consistent financial performance.

What is the dividend yield of THEMIS MEDICARE LTD.?

THEMIS MEDICARE LTD. offers a dividend yield of 0.36%, with a dividend rate of ₹0.5 per share.

What are the key financial metrics of THEMIS MEDICARE LTD.?

Key financial metrics include a trailing P/E ratio of 25.366001, forward P/E of , book value of ₹44.68, price-to-book ratio of 2.8386302, and a market capitalization of ₹11.75 billion.

What does THEMIS MEDICARE LTD. do?

Themis Medicare Limited, together with its subsidiaries, manufactures and sells pharmaceutical products in India and internationally. The company offers active pharmaceutical ingredients (APIs) and formulations for use in various therapeutic areas, including anti-tuberculosis, anti-malarials, cardiology, pain management, anti-infectives, haematinics, health and nutrition, anaesthesia, gynecology, and orthopedics. It also offers anti-inflammatory drugs and other drugs. The company was formerly known as Themis Chemicals and changed its name to Themis Medicare Limited in 2001. Themis Medicare Limited was founded in 1952 and is headquartered in Mumbai, India.

Loading...

₹ 0 0.00%

Loading... BSE: Loding... NSE: Themismed

About

Loading... ^[1]

Website BSE NSE

Market Cap ₹ 0 Cr.
Current Price ₹ 0
High / Low ₹ 0 / 0
Stock P/E
Dividend Yield 0 %
ROE 0 %
EPS 0
P/B Ratio 0
Net Profit Margin 0 %
Debt to Equity 0
ROCE 0 %
Interest Coverage 0 %

Stock News - Themismed

Latest updates related to Themismed

Sr No.	Title	Sentiment
1	More Unpleasant Surprises Could Be In Store For Themis Medicare Limited's (NSE:THEMISMED) Shares After Tumbling 27% Simply Wall St	🔄
2	Themis Medicare's (NSE:THEMISMED) earnings growth rate lags the 38% CAGR delivered to shareholders Simply Wall St	🔄
3	Has Themis Medicare Limited's (NSE:THEMISMED) Impressive Stock Performance Got Anything to Do With Its Fundamentals? Simply Wall St	🔄

Peer Comparison

Macro Industry: Loading.. | Sector: Loading.. | Industry: Loading.. | Basic Industry: Loading..

Loading peers table...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Loading data...

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Loading Profit & Loss data...

Compounded Sales Growth
10 Years:
5 Years:
3 Years:
TTM:

Compounded Profit Growth
10 Years:
5 Years:
3 Years:
TTM:

Stock Price CAGR
10 Years:
5 Years:
3 Years:
1 Year:

Return on Equity
10 Years:
5 Years:
3 Years:
Last Year:

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Shareholding Pattern

Numbers in percentages

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Delivery Data

Insider Data

Technical Data

Static Application Security Testing

Documents

Announcements

Annual reports

Right Issue

Credit ratings

Concalls

Explore More Stocks

ZOTA PENTAGON AMIABLE KRISHIVAL AUROIMPEX LOYALTEX RADIANTCMS ANMOL SUNDRMFAST GRASIM